Ani Pharmaceuticals (ANIP) Debt Ratio (2012 - 2026)

Ani Pharmaceuticals has disclosed Debt Ratio across 12 years of filings, most recently posting 0.21 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.21, down 9.18% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.21 (down 9.18% YoY), and the FY2025 annual result was 0.21, down 13.39% from the prior year.
• Debt Ratio came in at 0.21 for Q1 2026 at Ani Pharmaceuticals, roughly flat from 0.21 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.39 in Q3 2022 to a low of 0.21 in Q4 2025.
• The 5-year median for Debt Ratio is 0.31 (2024), against an average of 0.3.
• Across the five-year window, Debt Ratio advanced 1.21% in 2022 and declined 29.7% in 2024, its largest moves.
• Ani Pharmaceuticals' Debt Ratio stood at 0.38 in 2022, then retreated by 16.21% to 0.32 in 2023, then slipped by 21.55% to 0.25 in 2024, then decreased by 13.39% to 0.21 in 2025, then rose by 0.04% to 0.21 in 2026.
• The last three Debt Ratio figures came in at 0.21 (Q1 2026), 0.21 (Q4 2025), and 0.22 (Q3 2025), per Business Quant data.